Critical role of factors II and X during coumarin anticoagulation and their combined measurement with a new Fiix-prothrombin time

被引:17
作者
Gudmundsdottir, Brynja R. [1 ,2 ,3 ]
Francis, Charles W. [4 ]
Bjornsdottir, Alexia M. [1 ,2 ,3 ]
Nellbring, Moa [1 ,2 ,3 ]
Onundarson, Pall T. [1 ,2 ,3 ]
机构
[1] Landspitali Univ Hosp, Dept Lab Hematol, IS-101 Reykjavik, Iceland
[2] Landspitali Univ Hosp, Hemostasis Ctr, IS-101 Reykjavik, Iceland
[3] Univ Iceland, Sch Med, IS-101 Reykjavik, Iceland
[4] Univ Rochester, Strong Mem Hosp, Sch Med & Dent, Dept Hematol & Oncol, Rochester, NY 14642 USA
关键词
WHOLE-BLOOD COAGULATION; FACTOR-VII; ATRIAL-FIBRILLATION; WARFARIN; THERAPY; ANTIGEN; COAGULOPATHY; DABIGATRAN; MANAGEMENT; FIBRINOGEN;
D O I
10.1016/j.thromres.2011.12.013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Vitamin K antagonists (VKA) are monitored with prothrombin time ( PT) based assays that are equally sensitive to reductions in factors II, VII or X. We compared the effect of vitamin K dependent (VKD) coagulation factors on PT and also on rotational thromboelastometric (ROTEM) parameters. The PT was equally sensitive to reductions in factors II, VII or X but ROTEM parameters correlated poorly with the PT in anticoagulated patients plasmas. ROTEM parameters were more affected by mild and moderate reductions in FII or FX than by FVII or FIX which had little influence except at very low coagulant activity. We developed a modified PT that was sensitive only to reductions in factors II and X. The Fiix-PT (Fiix-INR) correlated well with PT (INR) but the Fiix-INR fluctuated less than the INR in an anticoagulated patient reflecting its insensitivity to FVII. The ROTEM results suggest that mild to moderate reductions in factors II or X are more important during clot formation than factors VII or IX. Reductions in FII and X may better reflect anticoagulation with VKA than FVII or IX. The new Fiix-PT may more accurately reflect the degree of therapeutic anticoagulation in patients treated with VKA than the current PT which is subject to a confounding variation caused by FVII. (c) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:674 / 681
页数:8
相关论文
共 31 条
[1]   Pharmacology and management of the vitamin K antagonists [J].
Ansell, Jack ;
Hirsh, Jack ;
Hylek, Elaine ;
Jacobson, Alan ;
Crowther, Mark ;
Palareti, Gualtiero .
CHEST, 2008, 133 (06) :160S-198S
[2]   Oral Rivaroxaban for Symptomatic Venous Thromboembolism. [J].
Bauersachs, Rupert ;
Berkowitz, Scott D. ;
Brenner, Benjamin ;
Buller, Harry R. ;
Decousus, Herve ;
Gallus, Alex S. ;
Lensing, Anthonie W. ;
Misselwitz, Frank ;
Prins, Martin H. ;
Raskob, Gary E. ;
Segers, Annelise ;
Verhamme, Peter ;
Wells, Phil ;
Agnelli, Giancarlo ;
Bounameaux, Henri ;
Cohen, Alexander ;
Davidson, Bruce L. ;
Piovella, Franco ;
Schellong, Sebastian .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (26) :2499-2510
[3]   Oral anticoagulation thresholds [J].
Brummel, KE ;
Paradis, SG ;
Branda, RF ;
Mann, KG .
CIRCULATION, 2001, 104 (19) :2311-2317
[4]   Dabigatran versus Warfarin in Patients with Atrial Fibrillation. [J].
Connolly, Stuart J. ;
Ezekowitz, Michael D. ;
Yusuf, Salim ;
Eikelboom, John ;
Oldgren, Jonas ;
Parekh, Amit ;
Pogue, Janice ;
Reilly, Paul A. ;
Themeles, Ellison ;
Varrone, Jeanne ;
Wang, Susan ;
Alings, Marco ;
Xavier, Denis ;
Zhu, Jun ;
Diaz, Rafael ;
Lewis, Basil S. ;
Darius, Harald ;
Diener, Hans-Christoph ;
Joyner, Campbell D. ;
Wallentin, Lars .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (12) :1139-1151
[5]  
Diener HC, 2010, LANCET NEUROL, V9, P1157, DOI 10.1016/S1474-4422(10)70274-X
[6]   Feasibility of Using Rotational Thromboelastometry to Assess Coagulation Status of Combat Casualties in a Deployed Setting [J].
Doran, Catherine M. ;
Woolley, Tom ;
Midwinter, Mark J. .
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2010, 69 :S40-S48
[7]   Thrombelastographic whole blood clot formation after ex vivo addition of plasma substitutes:: improvements of the induced coagulopathy with fibrinogen concentrate [J].
Fenger-Eriksen, C ;
Anker-Moller, E ;
Heslop, J ;
Ingerslev, J ;
Sorensen, B .
BRITISH JOURNAL OF ANAESTHESIA, 2005, 94 (03) :324-329
[8]  
FURIE B, 1984, BLOOD, V64, P445
[9]  
FURIE B, 1990, BLOOD, V75, P344
[10]   Monitoring recombinant factor VIIa treatment: Efficacy depends on high levels of fibrinogen in a model of severe dilutional coagulopathy [J].
Ganter, Michael T. ;
Schmuck, Saskia ;
Hamiel, Christine R. ;
Wischmeyer, Paul E. ;
Heule, Daniela ;
Zollinger, Andreas ;
Hofer, Christoph K. .
JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2008, 22 (05) :675-680